Literature DB >> 11719417

ABC of the upper gastrointestinal tract: Indigestion and non-steroidal anti-inflammatory drugs.

J M Seager1, C J Hawkey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11719417      PMCID： PMC1121700          DOI： 10.1136/bmj.323.7323.1236

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Non-steroidal anti-inflammatory drugs and peptic ulcers.

Authors:  C J Hawkey
Journal:  BMJ       Date:  1990-02-03

2.  Future treatments for arthritis: new NSAIDs, NO NSAIDs, or no NSAIDs?

Authors:  C J Hawkey
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

3.  A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.

Authors:  N D Yeomans; Z Tulassay; L Juhász; I Rácz; J M Howard; C J van Rensburg; A J Swannell; C J Hawkey
Journal:  N Engl J Med       Date:  1998-03-12       Impact factor: 91.245

4.  Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis.

Authors:  D Henry; L L Lim; L A Garcia Rodriguez; S Perez Gutthann; J L Carson; M Griffin; R Savage; R Logan; Y Moride; C Hawkey; S Hill; J T Fries
Journal:  BMJ       Date:  1996-06-22

5.  Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial.

Authors:  F E Silverstein; D Y Graham; J R Senior; H W Davies; B J Struthers; R M Bittman; G S Geis
Journal:  Ann Intern Med       Date:  1995-08-15       Impact factor: 25.391
  5 in total
  14 in total

1.  [Potential interactions of rheumatologic medications in the elderly].

Authors:  U Lange; U Müller-Ladner
Journal:  Orthopade       Date:  2012-07       Impact factor: 1.087

2.  Non-steroidal anti-inflammatory drugs: use and co-treatment with potentially interacting medications in the elderly.

Authors:  Kathrine F Vandraas; Olav Spigset; Milada Mahic; Lars Slørdal
Journal:  Eur J Clin Pharmacol       Date:  2010-04-20       Impact factor: 2.953

3.  Factors that influence prescribers in their selection and use of COX-2 selective inhibitors as opposed to non-selective NSAIDs.

Authors:  Anna I Gunnarsdóttir; Moira Kinnear
Journal:  Pharm World Sci       Date:  2005-08

Review 4.  NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options.

Authors:  Jørgen Naesdal; Kurt Brown
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

5.  Mechanism of action of novel NO-releasing furoxan derivatives of aspirin in human platelets.

Authors:  Catriona M Turnbull; Clara Cena; Roberta Fruttero; Alberto Gasco; Adriano G Rossi; Ian L Megson
Journal:  Br J Pharmacol       Date:  2006-05-15       Impact factor: 8.739

6.  Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK.

Authors:  Andrew Moore; Ceri Phillips; Elke Hunsche; James Pellissier; Simone Crespi
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

7.  Role of Helicobacter pylori infection in gastroduodenal damage in patients starting NSAID therapy: 4 Months follow-up study.

Authors:  Aleksandra Sokic-Milutinovic; Miodrag Krstic; Brigita Rozer-Smolovic; Tamara Alempijevic
Journal:  Dig Dis Sci       Date:  2010-01-22       Impact factor: 3.199

8.  Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study.

Authors:  R L Howard; A J Avery; P D Howard; M Partridge
Journal:  Qual Saf Health Care       Date:  2003-08

Review 9.  Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects.

Authors:  Martin Wehling
Journal:  Eur J Clin Pharmacol       Date:  2014-08-28       Impact factor: 2.953

10.  Efficacy and Safety of COX-2 Inhibitors in the Clinical Management of Arthritis: Mini Review.

Authors:  Sam T Mathew; Gayathri Devi S; V V Prasanth; B Vinod
Journal:  ISRN Pharmacol       Date:  2011-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.